Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

Clicks: 372
ID: 273814
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #2 of 2 articles by views in The Lancet. Oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Celgene.
Reference Key
f2015thechemotherapy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gay F;Oliva S;Petrucci MT;Conticello C;Catalano L;Corradini P;Siniscalchi A;Magarotto V;Pour L;Carella A;Malfitano A;Petrò D;Evangelista A;Spada S;Pescosta N;Omedè P;Campbell P;Liberati AM;Offidani M;Ria R;Pulini S;Patriarca F;Hajek R;Spencer A;Boccadoro M;Palumbo A;;
Journal The Lancet. Oncology
Year 2015
DOI
DOI not found
URL
https://www.pubmed.gov/26596670/
Keywords
australia transplantation National Center for Biotechnology Information NCBI NLM MEDLINE chemotherapy humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female male aged middle aged Comparative Study risk factors Clinical Trial Phase III Randomized Controlled Trial Multicenter Study Proportional Hazards Models time factors autologous disease progression antineoplastic combined chemotherapy protocols / adverse effects disease-free survival prednisone / adverse effects kaplan-meier estimate maintenance chemotherapy dexamethasone / therapeutic use antineoplastic combined chemotherapy protocols / therapeutic use* cyclophosphamide / therapeutic use adjuvant italy Melphalan / therapeutic use antonio palumbo lenalidomide multiple myeloma / mortality thalidomide / adverse effects thalidomide / analogs & derivatives* thalidomide / therapeutic use pmid:26596670 doi:10.1016/s1470-2045(15)00389-7 francesca gay stefania oliva czech republic hematopoietic stem cell transplantation* / adverse effects hematopoietic stem cell transplantation* / mortality multiple myeloma / diagnosis multiple myeloma / therapy* prednisone / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.